[Synchronous cervical intraepithelial neoplasia and cervical follicular non-Hodgkin lymphoma: report of a case].
Zhu
Hong
H
Xie
Jian-lan
JL
Yu
Ran
R
Gong
Ling-ping
LP
Zhou
Xiao-ge
XG
D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D018951:Antigens, CD20 / Q000378:metabolism; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000378:metabolism; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000601:surgery / Q000821:virology; D009367:Neoplasm Staging; D015260:Neprilysin / Q000378:metabolism; D030361:Papillomavirus Infections; D011241:Prednisone / Q000627:therapeutic use; D017464:Receptors, Complement 3d / Q000378:metabolism; D000069283:Rituximab; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000601:surgery / Q000821:virology; D014750:Vincristine / Q000627:therapeutic use; D002578:Uterine Cervical Dysplasia / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000601:surgery / Q000821:virology
D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D019941:Cyclin-Dependent Kinase Inhibitor p16; D017464:Receptors, Complement 3d; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D015260:Neprilysin; D011241:Prednisone